Document Detail

Pleuropulmonary complications of endoscopic variceal sclerotherapy.
MedLine Citation:
PMID:  2019188     Owner:  NLM     Status:  MEDLINE    
The most common pulmonary complication of EVS is pleural effusion. The most clinically significant pulmonary complication of EVS is delayed perforation with formation of esophagopleural or esophagobronchial fistula. Pneumonia, empyema, pulmonary infarction, and atelectasis can also occur. Endoscopic variceal sclerotherapy probably does not cause ARDS, but that issue remains unsettled. Transient relative pulmonary hypertension during EVS is probably of no clinical significance, but caution is urged when sclerosing varices in a patient with borderline right heart function.
J E Edling; B R Bacon
Related Documents :
22796538 - Electrical communication in branching arterial networks.
21492818 - Multidetector computed tomography in transcatheter aortic valve implantation.
24887838 - Management of mycotic femoral artery aneurysm with two resistant organisms.
22511008 - Hematopoietic progenitor cells and restenosis after carotid endarterectomy.
606298 - Recent experience with the baylor left ventricular bypass pump.
16959748 - Angiogenesis for the treatment of inoperable coronary disease: the future.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Chest     Volume:  99     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1991 May 
Date Detail:
Created Date:  1991-05-30     Completed Date:  1991-05-30     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1252-7     Citation Subset:  AIM; IM    
Section of Gastroenterology and Hepatology, Louisiana State University School of Medicine, Shreveport.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Esophageal and Gastric Varices / therapy*
Extravasation of Diagnostic and Therapeutic Materials
Gastrointestinal Hemorrhage / therapy*
Lung Diseases / etiology*
Mediastinitis / etiology
Pleural Effusion / etiology*
Sclerosing Solutions / adverse effects*
Sclerotherapy / adverse effects*
Reg. No./Substance:
0/Sclerosing Solutions

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Angiographic evolution of coronary atherosclerosis in patients receiving propranolol. A two-year fol...
Next Document:  Continuous lateral rotational therapy and nosocomial pneumonia.